Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
CRNX: Analyst Maintains "Market Outperform" but Lowers Price Tar
An analyst from Citizens has reiterated a “Market Outperform” rating for Crinetics Pharmaceuticals (CRNX) but has adjusted the price target downwards from $105 to $96. Despite this reduction, the move reflects continued confidence in the company’s market performance. Wall Street analysts project an average target price of $83.43 for CRNX, suggesting a significant upside from its current trading price.